J&J diabetic foot gel undergoes FDA safety review

03/28/2008 | CNNMoney · Reuters

The FDA will conduct a safety review of Johnson & Johnson's Regranex after a study found a potential link between the diabetic foot gel and a higher risk of cancer-related deaths. A J&J spokeswoman said the company is working with the FDA and remains "confident in the safety and effectiveness" of the product.

View Full Article in:

CNNMoney · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT